Effect of finasterid on COVID-19 treatment
Phase 3
- Conditions
- Corona virus pneumonia.COVID-19,virus not identifiedU07.2
- Registration Number
- IRCT20200505047318N1
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 80
Inclusion Criteria
having covid-19
age>50 years
male
hospitalization
Exclusion Criteria
use finasterid before covid-19
neurologic disease
psychiatric disease
drug users
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method